These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 3740826)

  • 1. [Modelling of rifampicin pharmacokinetics in experimental animals administered the drug intravenously and internally].
    Firsov AA; Umnova LV; Stepanov VM; Fomina IP
    Antibiot Med Biotekhnol; 1986 Jun; 31(6):445-9. PubMed ID: 3740826
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Pharmacokinetics of rifampicin in experimental animals].
    Koroleva VG; Fomina IP
    Antibiotiki; 1976 Aug; 21(8):722-5. PubMed ID: 999253
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bacterial pyrogens of different origin and pharmacokinetics of rifampicin.
    Lavický J; Urbanová Z; Celeda L; Rasková H; Kvĕtina J; Vanĕcek J; Krecek J
    Arzneimittelforschung; 1987 Jun; 37(6):713-6. PubMed ID: 3663270
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Pharmacokinetics of rifampicin administered intravenously to pulmonary tuberculosis patients].
    Ziia AV; Sokolov GB; Firsov AA
    Antibiot Med Biotekhnol; 1987 Mar; 32(3):223-7. PubMed ID: 3579252
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics and tissue distribution of rifametane, a new 3-azinomethyl-rifamycin derivative, in several animal species.
    Bruzzese T; Rimaroli C; Bonabello A; Mozzi G; Ajay S; Cooverj ND
    Arzneimittelforschung; 2000 Jan; 50(1):60-71. PubMed ID: 10683718
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of presystemic factors on the oral bioavailability of rifampicin following multiple dosing.
    Zhang JN; Liu XG; Zhu M; Chiu FC; Li RC
    J Chemother; 1998 Oct; 10(5):354-9. PubMed ID: 9822352
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Experimental pharmacodynamic study of rifampicin administered by various methods].
    Shapovalov VP; Mil'chenko KP; Kovalenko NN
    Antibiotiki; 1982 Jun; 27(6):434-7. PubMed ID: 7114830
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rifampin in the horse: comparison of intravenous, intramuscular, and oral administrations.
    Burrows GE; MacAllister CG; Beckstrom DA; Nick JT
    Am J Vet Res; 1985 Feb; 46(2):442-6. PubMed ID: 3994110
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Pharmacokinetic study of aclarubicin. The pharmacokinetics of the preparation and its biologically active metabolites in the blood of rats].
    Geodakian SV; Firsov AA; Fomina IP
    Antibiot Med Biotekhnol; 1987 Oct; 32(10):768-72. PubMed ID: 3480699
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Pharmacokinetic study of eremomycin in an experiment].
    Filippos'iants ST; Malkova IV
    Antibiot Med Biotekhnol; 1987 Jul; 32(7):511-6. PubMed ID: 3118795
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum and urine concentrations of rifampicin administered by intravenous infusion in man.
    Acocella G; Bonollo L; Mainardi M; Margaroli P; Tenconi LT
    Arzneimittelforschung; 1977; 27(6):1221-6. PubMed ID: 578447
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of cholestyramine on the pharmacokinetics of rosiglitazone and its metabolite, desmethylrosiglitazone, after oral and intravenous dosing of rosiglitazone: impact on oral bioavailability, absorption, and metabolic disposition in rats.
    Muzeeb S; Venkatesh P; Mullangi R; Srinivas NR
    Xenobiotica; 2006 Sep; 36(9):838-56. PubMed ID: 16971347
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics of 4-acetylaminophenylacetic acid. 1st communication: absorption, distribution, metabolism and excretion in mice, rats, dogs and monkeys after single administration of 14C-labeled compound.
    Sugihara K; Morino A; Nomura A; Iida S; Sugiyama M
    Arzneimittelforschung; 1990 Jul; 40(7):800-5. PubMed ID: 2222556
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Comparative effectiveness of the enteral and intravenous administration of rifampicin in treating experimental tuberculosis in rabbits].
    Bondarev IM; Mozhokina GN; Novoselova VP; Kovaleva LA
    Antibiot Med Biotekhnol; 1986 May; 31(5):378-81. PubMed ID: 2873786
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical pharmacokinetics of rifampicin.
    Acocella G
    Clin Pharmacokinet; 1978; 3(2):108-27. PubMed ID: 346286
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oral and intravenous trichloroethylene pharmacokinetics in the rat.
    D'Souza RW; Bruckner JV; Feldman S
    J Toxicol Environ Health; 1985; 15(5):587-601. PubMed ID: 4046066
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nonlinear oral pharmacokinetics of the alpha-antagonist 4-amino-5-(4-fluorophenyl)-6,7-dimethoxy-2-[4-(morpholinocarbonyl)-perhydro-1,4-diazepin-1-yl]quinoline in humans: use of preclinical data to rationalize clinical observations.
    Harrison A; Betts A; Fenner K; Beaumont K; Edgington A; Roffey S; Davis J; Comby P; Morgan P
    Drug Metab Dispos; 2004 Feb; 32(2):197-204. PubMed ID: 14744941
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics of cefixime after oral and intravenous doses in dogs: bioavailability assessment for a drug showing nonlinear serum protein binding.
    Bialer M; Wu WH; Look ZM; Silber BM; Yacobi A
    Res Commun Chem Pathol Pharmacol; 1987 Apr; 56(1):21-32. PubMed ID: 3589152
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Action of antibiotic 1719 from a group of diazo compounds on hematopoiesis in laboratory animals and its pharmacokinetics].
    Vertogradova TP; Kunrat IA
    Antibiotiki; 1975 Jan; 20(1):26-31. PubMed ID: 1122124
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Pharmacokinetics of the new antitumor antibiotic reumycin in an experiment: the prediction of the human pharmacokinetic profiles].
    Firsov AA; Geodakian SV; Terent'eva TG; Fomina IP
    Antibiot Med Biotekhnol; 1985 Apr; 30(4):296-301. PubMed ID: 4026251
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.